Nicole Brandt, PharmD | Amy Davidoff  |  Thomas Shaffer, MHS
Linda Simoni-Wastila, BSPharm, PhD 
Bruce Stuart, PhD | Lirong Zhao 
Ilene Zuckerman, PharmD, PhD

Bruce Stuart, PhD

Bruce Stuart, PhD, Professor and Executive Director of the Peter Lamy Center on Drug Therapy and Aging is an economist and health services researcher.  He received his economics training at Whitman College and Washington State University.  He began his career in health services research as an economic analyst and later as Director of the Health Research Division in the Michigan Medicaid program in the early 1970s. Leaving state government for academe, Dr. Stuart taught health economics, finance, and research methods at the University of Massachusetts and The Pennsylvania State University.  In 1997 he joined the faculty of the University of Maryland’s School of Pharmacy as the Parke-Davis endowed Chair in Geriatric Pharmacotherapy and was selected as a Maryland Eminent Scholar for his work in geriatric drug use. Dr. Stuart is on the editorial boards of Health Affairs and the American Journal of Geriatric Pharmacotherapy and serves on scientific review committees for AHRQ, the National Science Foundation, and various foundations. 

Dr. Stuart is an experienced research investigator having directed over 40 grants and contracts. Among his recently completed projects are a study of insurance effects on drug use for vulnerable elderly populations for The Commonwealth Fund, an analysis of cost differences between demented and non-demented nursing home residents for NIA, and a contract for CMS evaluating the persistence of prescription drug spending for Medicare beneficiaries over time. His current research includes a grant from The Commonwealth Fund to benchmark drug utilization patterns for elders with 8 common chronic diseases, a Robert Wood Johnson Foundation grant to study the impact of coverage gaps on medication use, and studies of medication effectiveness for treating dementia (AHRQ) and diabetes (CMS).  Dr. Stuart heads the University of Maryland DEcIDE Research Center, one of 13 national centers funded by AHRQ to conduct comparative drug effectiveness studies.

Dr. Stuart can be reached at 410-706-5389 or emailed at bstuart@rx.umaryland.edu.

Research Methods II students click here for class information.

Recent Publications:

Stuart, B., Briesacher, B., Doshi, J., Shea, D., and Wrobel, M. (2006) "Will Part D Produce savings in Part A and Part B? The Impact of Prescription Drug Coverage on Medicare Program Expenditures:" Inquiry, forthcoming.

Shea, D., Terza, J., Stuart B., Briesacher., (2006) "Estimating the Effects of Prescription Drug Coverage for Medicare Beneficiaries," Health Services Research, in press

Simoni-Wastila, L., Shaffer, T., Stuart, B. (2006) "Over-the-Counter Medication Use in Nurshing Homes: Implications for Practice and Policy," Journal of the American Geriatrics Society, in press.

Stuart, B., Singhal, P. (2006)  "The Stability of Medicaid Coverage for Low Income Dually Eligible Medicare Beneficiaries."  Menlo Park, CA: The Henry J. Kaiser Family Foundation. Publication No. 7512, http://www.kff.org/medicare/7512.cfm.

Briesacher, B., Stuart, B., Poisal, J., Doshi, J., Singhal P., (2006) "Methodological Issues in Estimating Prescription Drug Coverage Using the Medicare Current Beneficiary Survey" AARP: Washington DC  In press.

Stuart, B., Fennell, M., Sun, R., Campbell, S. (2006)  “Financial Correlates and Consequences of Rural Hospital Long Term Care Strategies,” Health Care Management Review, 31(2):145-155.

Stuart, B. (2006) “Where’s the Beef? Assessing the Returns from the New Medicare Drug Benefit,” in Public Policy and Responsibility Across the Generations,”  R. Pruchno, M. Smyer, and P. Byrne. (eds), Baltimore: Johns Hopkins Press, In press

Zuckerman, I., Lee, E., Wutoh, A., Xue, Z., Stuart, B. (2006)  “Application of Regression-Discontinuity Analysis in Pharmaceutical Healthcare Research.”  Health Services Research.  41(2):550-562.

Stuart, B., Simoni-Wastila, L., Baysac, F., Shaffer, T., Shea, D. (2006)“Coverage and Use of Prescription Drugs in Nursing Homes: Implications for the Medicare Modernization Act,” Medical Care, 44(3):243-249

Kamal-Bahl. S., Stuart, B., Beers, M. (2005) “National Trends and Predictors of Propoxyphene Use in Community-Dwelling Elderly Patients,” American Journal of Geriatric Pharmacotherapy 3(3):186-194.

Zuckerman, I., Hernandez, J., Gruber-Baldini, A., Hebel, J., Stuart, B., Zimmerman, S., Magaziner, J., (2005) “Dementia and Potentially Inappropriate Prescribing Before and After Nursing home Admission,”  American Journal of Geriatric Pharmacotherapy, 3(4):246-254.

Briesacher, B., Stuart, B., Doshi, J., and Wrobel, M. (2005)  “Medicare Beneficiaries and the Impact of Gaining Prescription Drug Coverage on Inpatient and Physician Spending,”  Health Services Research, 40(5, Part 1):1279-1296).

Stuart, B., Gruber-Baldini, A., Fahlman, C., Quinn, C., Burton, L., Zuckerman, I., Hebel, J., Zimmerman, S., Singhal, P., Magaziner, J.,  (2005)  “Medicare Cost Differences Between Nursing Home Patients Admitted with and without Dementia.” The Gerontologist, 45:505-515

Stuart, B., Briesacher, B., Shea, D., Cooper, B., Baysac, F., Limcangco, R., (2005) “Riding the Rollercoaster: The Ups and Downs in Out-of-Pocket Spending Under the New Medicare Benefit,” Health Affairs, 24(4):1022-1031.

Briesacher, B., Limcangco, R., Simoni-Wastila, L., Doshi, J., Levens, S., Shea, D., Stuart, B.  (2005) “The Quality of Antipsychotic Prescribing in Nursing Homes,” Archives of Internal Medicine, 165 (June 13, 2005):1280-1285.

Stuart, B., Simoni-Wastila, L., Chauncey. D. (2005) Assessing the Impact of Coverage Gaps in the Medicare Part D Drug Benefit, Health Affairs, Web Exclusive, April. http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w5.167.  Print version: Health Affairs Web Exclusives Supplement 24(Supp 1): W5-167-W5-179.